Julia Salaverría Monfort
Director/Board Member at Cecabank SA
Network origin in Julia Salaverría Monfort first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona.
24
| Private Company | Investment Managers | 24 |
Universidad Autónoma de Madrid
22
| College/University | Other Consumer Services | 22 |
Cecabank SA
 Cecabank SA Investment Banks/BrokersFinance Cecabank SA is engaged in the provision of financial, technological and consultancy services and products to savings banks, associated organizations, banks and other customers in the financial sector. The company was founded in 2012 and is headquartered in Madrid, Spain.
11
| Subsidiary | Investment Banks/Brokers | 11 |
University of Deusto
5
| College/University | Other Consumer Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Julia Salaverría Monfort via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Instituto de Empresa SL | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal Graduate Degree | |
| Universitat Pompeu Fabra | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
| Instituto de Estudios Superiores de la Empresa | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
| University of Barcelona | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Medlumics SL
 Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| BANCO SANTANDER, S.A. | Major Banks | Corporate Officer/Principal Director/Board Member President | |
| TELEFÓNICA, S.A. | Specialty Telecommunications | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Escuela Superior de Administración y Dirección de Empresas | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| ACERINOX S.A. | Steel | Director/Board Member Director/Board Member | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sociedad de Gestión de Activos Procedentes de La
 Sociedad de Gestión de Activos Procedentes de La Investment Banks/BrokersFinance Sociedad de Gestión de Activos Procedentes de la Reestructuración Bancaria SA provides asset management services. Its service portfolio includes real estate properties. The company was founded in November 2012 and is headquartered in Madrid, Spain. | Investment Banks/Brokers | Chairman Director/Board Member | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
| Círculo de Empresarios | Corporate Secretary Corporate Officer/Principal | ||
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder | |
| CAIXABANK, S.A. | Regional Banks | Director/Board Member Director of Finance/CFO | |
| University of Alcalá | College/University | Doctorate Degree Graduate Degree | |
| CORPORACIÓN FINANCIERA ALBA, S.A. | Investment Managers | Director/Board Member Chief Executive Officer | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Founder | |
| ENDESA, S.A. | Electric Utilities | Director/Board Member Director/Board Member | |
Acciona Generación Renovable SA
 Acciona Generación Renovable SA Alternative Power GenerationUtilities Acciona Generación Renovable SA engages in the development and construction of power generation facilities. It operates and maintains wind farms, solar parks, hydroelectric stations, and biomass production plants located throughout Europe, Africa, and the Americas. It also provides technical and environmental consulting services, as well as project management and renewable technology research. The company was founded on December 9, 2002 and is headquartered in Sarriguren, Spain. | Alternative Power Generation | President Human Resources Officer | |
| ACCIONA, S.A. | Engineering & Construction | Director/Board Member Corporate Officer/Principal | |
KPMG Abogados SL
 KPMG Abogados SL Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG Abogados SL provides legal services. The company is based in Madrid, Spain and was founded in 1987. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SACYR, S.A. | Engineering & Construction | Director/Board Member Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| GENERAL DE ALQUILER DE MAQUINARIA, S.A. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
| REPSOL S.A. | Integrated Oil | Director of Finance/CFO General Counsel | |
| The University of the Basque Country | College/University | Doctorate Degree Undergraduate Degree | |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
| ALMIRALL, S.A. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chairman Director of Finance/CFO | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| TIGENIX NV | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Abanca Corporación Industrial y Empresarial SL
 Abanca Corporación Industrial y Empresarial SL Investment Banks/BrokersFinance Abanca Corporación Industrial y Empresarial SL engages in the operation as a banking and investment firm. The company was founded on June 26, 1987 and is headquartered in La Coruña, Spain. | Investment Banks/Brokers | Chief Executive Officer Director/Board Member | |
| PROMOTORA DE INFORMACIONES, S.A. | Publishing: Books/Magazines | Chief Operating Officer Director/Board Member | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
NCG Bank
 NCG Bank Regional BanksFinance NCG Bank provides banking services. | Regional Banks | Chief Executive Officer Director/Board Member | |
Asabys Partners SGEIC SA
 Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners SGEIC SA (Asabys Partners) is an independent venture capital firm founded in 2019 by Clara Campàs-Moya and Josep Lluís Sanfeliu Benet. The firm is headquartered in Barcelona, Spain. | Investment Managers | Founder Private Equity Investor | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder | |
| University of Pittsburgh | College/University | Doctorate Degree | |
| West Virginia University | College/University | Graduate Degree | |
Compañía de Seguros y Reaseguros SA
 Compañía de Seguros y Reaseguros SA Life/Health InsuranceFinance Part of CaixaBank SA, Compañía de Seguros y Reaseguros SA is a Spanish company that provides health insurances. The company is based in Madrid, Spain. Compañía de Seguros y Reaseguros was acquired by Cía de Seguros Adeslas SA from Sociedad Estatal de Participaciones Industriales SA on October 01, 2005 for $19.05 million. | Life/Health Insurance | Director/Board Member | |
Confederación Española de Cajas de Ahorros SA
 Confederación Española de Cajas de Ahorros SA Miscellaneous Commercial ServicesCommercial Services Confederación Española de Cajas de Ahorros SA provides consulting and support services to savings banks. It operates as an association of 45 savings banks. The company provides risk management and financial services, such as discount centers, securities, fund depository, and cash departments, centralized account administration, and trading rooms. It is headquartered in Madrid, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
Unicaja Gestión de Activos Inmobiliarios SA
 Unicaja Gestión de Activos Inmobiliarios SA Real Estate DevelopmentFinance Part of Unicaja Banco SA, Unicaja Gestion de Activos Inmobiliarios SA is a real estate agency based in Malaga, Spain. The Spanish company operates in the real estate industry, providing various services related to the buying, selling, and management of properties. | Real Estate Development | Director/Board Member | |
| Inmobiliaria Acinipo SL | Director/Board Member | ||
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder |
Statistics
International
| Spain | 38 |
| United States | 7 |
| Switzerland | 4 |
| Argentina | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 11 |
| Finance | 11 |
| Commercial Services | 4 |
| Utilities | 3 |
Operational
| Director/Board Member | 261 |
| Corporate Officer/Principal | 98 |
| Independent Dir/Board Member | 52 |
| Chairman | 47 |
| Undergraduate Degree | 34 |
Most connected contacts
- Stock Market
- Insiders
- Julia Salaverría Monfort
- Company connections
